Maria Gessica Ciulla

Dr. Maria Gessica Ciulla

Dipartimento di Scienze della Vita, University of Modena and Reggio Emilia, Modena, Emilia-Romagna, Italy
orcid
Assistant Professor, University of Modena and Reggio Emilia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2023 in Microbial Biotechnology
Verified
Journal Article
Open access
Maria Gessica CiullaMaria Gessica Ciulla
Maria Gessica Ciulla
FGFabrizio Gelain
Fabrizio Gelain
Antimicrobial peptides play a crucial role in innate immunity, whose components are mainly peptide‐based molecules with antibacterial properties. Indeed, the exploration of the immune system over the past 40 years has revealed a number of natural peptides playing a pivotal role in the defence mechanisms of vertebrates and invertebrates, including amphibians, insects, and mammalians. This review provides a discussion regarding the antibacterial mechanisms of peptide‐based agents and their structure–activity relationships (SARs) with the aim of describing a topic that is not yet fully explored. Some growing evidence suggests that innate immunity should be strongly considered for the development of novel antibiotic peptide‐based libraries. Also, due to the constantly rising concern of antibiotic resistance, the development of new antibiotic drugs is becoming a priority of global importance. Hence, the study and the understanding of defence phenomena occurring in the immune system may inspire the development of novel antibiotic compound libraries and set the stage to overcome drug‐resistant pathogens. Here, we provide an overview of the importance of peptide‐based antibacterial sources, focusing on accurately selected molecular structures, their SARs including recently introduced modifications, their latest biotechnology applications, and their potential against multi‐drug resistant pathogens. Last, we provide cues to describe how antibacterial peptides show a better scope of action selectivity than several anti‐infective agents, which are characterized by non‐selective activities and non‐targeted actions toward pathogens.

27 November 2018 in Organic & Biomolecular Chemistry
Verified
Journal Article
Open access
PDF file
Maria Gessica CiullaMaria Gessica Ciulla
Maria Gessica Ciulla
SZStefan Zimmermann
Stefan Zimmermann
KKKamal Kumar
Kamal Kumar
In this review, cascade reaction based synthesis strategies delivering biologically intriguing indole polycycles are presented.

20 October 2023 in Gels
Verified
Journal Article
Open access
PDF file
Maria Gessica CiullaMaria Gessica Ciulla
Maria Gessica Ciulla
AMAlessio Massironi
Alessio Massironi
MSMichela Sugni
Michela Sugni
MEMatthew Ensign
Matthew Ensign
Stefania MARZORATIStefania MARZORATI
Stefania MARZORATI
MFMahdi Forouharshad
Mahdi Forouharshad
In this review, we focused on recent efforts in the design and development of materials with biomimetic properties. Innovative methods promise to emulate cell microenvironments and tissue functions, but many aspects regarding cellular communication, motility, and responsiveness remain to be explained. We photographed the state-of-the-art advancements in biomimetics, and discussed the complexity of a “bottom-up” artificial construction of living systems, with particular highlights on hydrogels, collagen-based composites, surface modifications, and three-dimensional (3D) bioprinting applications. Fast-paced 3D printing and artificial intelligence, nevertheless, collide with reality: How difficult can it be to build reproducible biomimetic materials at a real scale in line with the complexity of living systems? Nowadays, science is in urgent need of bioengineering technologies for the practical use of bioinspired and biomimetics for medicine and clinics.

1 August 2018 in Tetrahedron Letters
Verified
Journal Article
Closed access
Maria Gessica CiullaMaria Gessica Ciulla
Maria Gessica Ciulla
KKKamal Kumar
Kamal Kumar

29 August 2022 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
CDCaitlin Davies
Caitlin Davies
LDLara Dötsch
Lara Dötsch
Maria Gessica CiullaMaria Gessica Ciulla
Maria Gessica Ciulla
EHElisabeth Hennes
Elisabeth Hennes
KYKei Yoshida
Kei Yoshida
HWHerbert Waldmann
Herbert Waldmann
Natural product (NP)‐inspired design principles provide invaluable guidance for bioactive compound discovery. Pseudo‐natural products (PNPs) are de novo combinations of NP fragments to target biologically relevant chemical space not covered by NPs. We describe the design and synthesis of apoxidoles, a novel pseudo‐NP class, whereby indole‐ and tetrahydropyridine fragments are linked in monopodal connectivity not found in nature. Apoxidoles are efficiently accessible by an enantioselective [4+2] annulation reaction. Biological evaluation revealed that apoxidoles define a new potent type IV inhibitor chemotype of indoleamine 2,3‐dioxygenase 1 (IDO1), a heme‐containing enzyme considered a target for the treatment of neurodegeneration, autoimmunity and cancer. Apoxidoles target apo‐IDO1, prevent heme binding and induce unique amino acid positioning as revealed by crystal structure analysis. Novel type IV apo‐IDO1 inhibitors are in high demand, and apoxidoles may provide new opportunities for chemical biology and medicinal chemistry research.

27 June 2023
Verified
Journal Article
Open access
PDF file
Maria Gessica CiullaMaria Gessica Ciulla
Maria Gessica Ciulla
MCMonica Civera
Monica Civera
SSSara Sattin
Sara Sattin
KKKamal Kumar
Kamal Kumar
Peptides constitute an important component of Nature’s pharmacy and they play a significant role in several signaling pathways acting as natural biological messengers. While nature has mastered the cycle of creation, application, and destruction of large and short peptides to the benefit of the host organism, organic and medicinal chemists have in their capacity and small steps, made big developments in the field of peptide synthesis as well as in developing them as therapeutics. In comparison to their big counterparts, i.e. proteins, short peptides encompass several advantages, from the ease of synthesis to their physico-chemical properties. However, the real challenge for in vivo application of therapeutic peptides is to overcome their low plasma availability and their fast enzymatic degradation. This review briefly covers the relevant areas of medicinally important short peptides and the recent developments made to turn these peptides into therapeutics. Also presented in this article are important efforts and strategies used to overcome some of the inherent limitations of peptidic molecules and thereby facilitate their progression in the clinical phases towards approved drugs.